Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Home » Pharmacology » 7-TM Receptors » Peptide Receptors » Angiotensin Receptors » Angiotensin AT1 Receptors
Angiotensin AT1 Receptors
More Information »The angiotensin1 receptor (AT1) is a member of the angiotensin group of G-protein-coupled receptors that also includes AT2 and AT4. They are located primarily in the liver, kidney, adrenal gland and lung. AT1 receptors preferentially bind angiotensin II.
Angiotensin AT1 Receptor Products
Antagonists |
|
Cat.No. |
Product Name / Activity |
| 4553 | Azilsartan |
| Potent AT1 receptor inverse agonist; antihypertensive | |
| 4791 |
Candesartan
|
| AT1 receptor antagonist | |
| 4792 |
Candesartan cilexetil
|
| Prodrug of candesartan (Cat. No. 4791), an AT1 receptor antagonist | |
| 1849 | EMD 66684 |
| Potent, selective non-peptide AT1 antagonist | |
| 4696 | Eprosartan mesylate |
| Potent and selective AT1 receptor antagonist | |
| 3798 | Losartan potassium |
| Selective, nonpeptide AT1 antagonist | |
| 4616 | Olmesartan |
| Potent AT1 antagonist; metabolite of Olmesartan medoxomil (Cat. No. 4620) | |
| 4620 | Olmesartan medoxomil |
| Selective non-peptide AT1 antagonist; prodrug of Olmesartan | |
| 4216 | Valsartan |
| High affinity, selective AT1 antagonist | |
| 1211 | ZD 7155 hydrochloride |
| Selective non-peptide AT1 antagonist | |
Related Categories
Quick Order
Find multiple products by catalog number
Tocris Events
Meet your representative
The Role of Cytokines and Signaling in Inflammation
October 15, 2013
Bonn, Germany





